EU approves Ilaris (Novartis) to treat Gouty Arthritis

The Lancet Oncology, has published online ahead of its April print edition the results from the randomized , double-blind, placebo- controlled Phase II clinical trial of Enobosarm from GTx to assess its effects on Muscle Wasting …

See the original post:
EU approves Ilaris (Novartis) to treat Gouty Arthritis

No comments yet.

TOP